4.6 Article

Analysis of HDAC6 and BAG3-Aggresome Pathways in African Swine Fever Viral Factory Formation

Journal

VIRUSES-BASEL
Volume 7, Issue 4, Pages 1823-1831

Publisher

MDPI AG
DOI: 10.3390/v7041823

Keywords

-

Categories

Funding

  1. Ministerio de Economia y Competitividad of Spain [AGL2009-09209, AGL2012-34533]

Ask authors/readers for more resources

African swine fever virus (ASFV) is a double-stranded DNA virus causing a hemorrhagic fever disease with high mortality rates and severe economic losses in pigs worldwide. ASFV replicates in perinuclear sites called viral factories (VFs) that are morphologically similar to cellular aggresomes. This fact raises the possibility that both VFs and aggresomes may be the same structure. However, little is known about the process involved in the formation of these viral replication platforms. In order to expand our knowledge on the assembly of ASFV replication sites, we have analyzed the involvement of both canonical aggresome pathways in the formation of ASFV VFs: HDAC6 and BAG3. HDAC6 interacts with a component of the dynein motor complex (dynactin/p150(Glued)) and ubiquitinated proteins, transporting them to the microtubule-organizing center (MTOC) and leading to aggresome formation, while BAG3 is mediating the recruitment of non-ubiquitinated proteins through a similar mechanism. Tubacin-mediated HDAC6 inhibition and silencing of BAG3 pathways, individually or simultaneously, did not prevent ASFV VF formation. These findings show that HDAC6 and Bag3 are not required for VFs formation suggesting that aggresomes and VFs are not the same structures. However, alternative unexplored pathways may be involved in the formation of aggresomes.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Pharmacology & Pharmacy

Antiviral drugs targeting endosomal membrane proteins inhibit distant animal and human pathogenic viruses

I Galindo, U. Garaigorta, F. Lasala, M. A. Cuesta-Geijo, P. Bueno, C. Gil, R. Delgado, P. Gastaminza, C. Alonso

Summary: The study demonstrates that drug compounds targeting endosomal membrane proteins show potent inhibitory effects on the entry of SARS-CoV-2, EBOV, and ASFV into cells, suggesting the potential of these compounds as broad-spectrum antivirals targeting the endocytic pathway proteins.

ANTIVIRAL RESEARCH (2021)

Article Pharmacology & Pharmacy

Identification of potential inhibitors of protein-protein interaction useful to fight against Ebola and other highly pathogenic viruses

Fatima Lasala, Alfonso Garcia-Rubia, Carlos Requena, Inmaculada Galindo, Miguel Angel Cuesta-Geijo, Isabel Garcia-Dorival, Paula Bueno, Nuria Labiod, Joanna Luczkowiak, Ana Martinez, Nuria E. Campillo, Covadonga Alonso, Rafael Delgado, Carmen Gil

Summary: Despite the lack of currently licensed antiviral drugs for treating Ebola virus disease, efforts are ongoing to identify new drugs to combat EBOV. Virtual screening has led to the discovery of small organic molecules with potent inhibitory action against EBOV infection, paving the way for hit to lead optimization programs toward successful candidates.

ANTIVIRAL RESEARCH (2021)

Article Virology

African Swine Fever Virus Ubiquitin-Conjugating Enzyme Is an Immunomodulator Targeting NF-κB Activation

Lucia Barrado-Gil, Ana del Puerto, Inmaculada Galindo, Miguel Angel Cuesta-Geijo, Isabel Garcia-Dorival, Carlos Maluquer de Motes, Covadonga Alonso

Summary: The African swine fever virus early protein UBCv1 has been found to modulate innate immune response by targeting NF-kappa B and AP-1 pathways. Its inhibitory activity acts upstream at the level of IKK beta, blocking key events in NF-kappa B signaling. Despite its known ubiquitination capacity, UBCv1's immunomodulatory activity seems to be separate from this function.

VIRUSES-BASEL (2021)

Article Pharmacology & Pharmacy

Identification of Niemann-Pick C1 protein as a potential novel SARS-CoV-2 intracellular target

Isabel Garcia-Dorival, Miguel Angel Cuesta-Geijo, Lucia Barrado-Gil, Inmaculada Galindo, Urtzi Garaigorta, Jesus Urquiza, Ana del Puerto, Nuria E. Campillo, Ana Martinez, Pablo Gastaminza, Carmen Gil, Covadonga Alonso

Summary: The study found a novel interaction between the SARSCoV-2 nucleoprotein (N) and the cholesterol transporter NPC1, and identified compounds that can reduce viral infection, highlighting the importance of NPC1 for SARS-CoV-2 infection and suggesting a potential new therapeutic target against COVID-19.

ANTIVIRAL RESEARCH (2021)

Article Microbiology

New insights into the role of endosomal proteins for African swine fever virus infection

Miguel Angel Cuesta-Geijo, Isabel Garcia-Dorival, Ana del Puerto, Jesus Urquiza, Inmaculada Galindo, Lucia Barrado-Gil, Fatima Lasala, Ana Cayuela, Carlos Oscar S. Sorzano, Carmen Gil, Rafael Delgado, Covadonga Alonso

Summary: The inner viral membrane proteins of African swine fever virus (ASFV) interact with endosomal proteins, potentially playing a crucial role in the viral entry process. Silencing or knockout of these proteins affects different stages of ASFV infection, and in some cases, prevents the virus from entering the cytoplasm from endosomes. These findings provide new insights into the role of endosomal proteins in ASFV infection.

PLOS PATHOGENS (2022)

Article Biochemistry & Molecular Biology

Effect of Clinically Used Microtubule Targeting Drugs on Viral Infection and Transport Function

Maria Angela Oliva, Carlota Tosat-Bitrian, Lucia Barrado-Gil, Francesca Bonato, Inmaculada Galindo, Urtzi Garaigorta, Beatriz Alvarez-Bernad, Rebeca Paris-Ogayar, Daniel Lucena-Agell, Juan Francisco Gimenez-Abian, Isabel Garcia-Dorival, Jesus Urquiza, Pablo Gastaminza, Jose Fernando Diaz, Valle Palomo, Covadonga Alonso

Summary: Microtubule targeting agents have potential in antiviral drug research, and some clinically used drugs have shown significant inhibitory effects on viral infections. However, their mechanism of action is complex and the relationship with intracellular transport is unclear.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Chemistry, Medicinal

N?-Phenylacetohydrazide Derivatives as Potent Ebola Virus Entry Inhibitors with an Improved Pharmacokinetic Profile

Alfonso Garcia-Rubia, Fatima Lasala, Tiziana Ginex, Marcos Morales-Tenorio, Catherine Olal, Michelle Heung, Paola Oquist, Inmaculada Galindo, Miguel Aprimengel Cuesta-Geijo, Jose M. Casasnovas, Nuria E. Campillo, Angeles Canales, Covadonga Alonso, Ana Martinez, Cesar Munoz-Fontela, Rafael Delgado, Carmen Gil

Summary: Ebola virus (EBOV), a single-strand RNA virus in the Filoviridae family, has been responsible for significant outbreaks since 2013. In this study, a new series of compounds were synthesized and found to inhibit EBOV infection by acting as virus entry inhibitors. The compounds were evaluated for their inhibitory activity against surrogate models and replicative EBOV, and their biological target was elucidated through various experiments. Additionally, their therapeutic potential was confirmed through in vitro metabolic stability and in vivo pharmacokinetic studies.

JOURNAL OF MEDICINAL CHEMISTRY (2023)

Article Virology

Elucidation of the Cellular Interactome of African Swine Fever Virus Fusion Proteins and Identification of Potential Therapeutic Targets

Isabel Garcia-Dorival, Miguel angel Cuesta-Geijo, Inmaculada Galindo, Ana del Puerto, Lucia Barrado-Gil, Jesus Urquiza, Covadonga Alonso

VIRUSES-BASEL (2023)

No Data Available